OTC-oriented pharmaceutical firms struggling to boost sales

Published: 2003-05-29 06:57:00

Updated: 2003-05-29 06:57:00

OTC pharmaceutical firms are moving to increase the sales of summer-season drugs towards the domestic pharmacy market as part of their efforts to boost their bottom lines.

These firms are offering lots of premiums to safeguard better display location of their OTCs at pharmacy, including other...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK